These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28723585)

  • 1. Clinical utility of contrast-enhanced spectral mammography as an adjunct for tomosynthesis-detected architectural distortion.
    Patel BK; Naylor ME; Kosiorek HE; Lopez-Alvarez YM; Miller AM; Pizzitola VJ; Pockaj BA
    Clin Imaging; 2017; 46():44-52. PubMed ID: 28723585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.
    Travieso-Aja MDM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Vega Benítez V; Pérez-Luzardo O
    Radiol Med; 2019 Oct; 124(10):1006-1017. PubMed ID: 31250270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies.
    Bellini C; Pugliese F; Bicchierai G; Amato F; De Benedetto D; Di Naro F; Boeri C; Vanzi E; Migliaro G; Incardona L; Tommasi C; Orzalesi L; Miele V; Nori J
    Breast Cancer; 2024 Sep; 31(5):851-857. PubMed ID: 38811515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tomosynthesis-Guided Vacuum-Assisted Breast Biopsy of Architectural Distortion Without a Sonographic Correlate: A Retrospective Review.
    Ambinder EB; Plotkin A; Euhus D; Mullen LA; Oluyemi E; Di Carlo P; Philip M; Panigrahi B; Cimino-Mathews A; Myers KS
    AJR Am J Roentgenol; 2021 Oct; 217(4):845-854. PubMed ID: 33147055
    [No Abstract]   [Full Text] [Related]  

  • 6. Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment.
    Tardivel AM; Balleyguier C; Dunant A; Delaloge S; Mazouni C; Mathieu MC; Dromain C
    Breast J; 2016 Sep; 22(5):520-8. PubMed ID: 27345656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided diagnosis of contrast-enhanced spectral mammography: A feasibility study.
    Patel BK; Ranjbar S; Wu T; Pockaj BA; Li J; Zhang N; Lobbes M; Zhang B; Mitchell JR
    Eur J Radiol; 2018 Jan; 98():207-213. PubMed ID: 29279165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
    Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
    J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Luczyńska E; Heinze S; Adamczyk A; Rys J; Mitus JW; Hendrick E
    Anticancer Res; 2016 Aug; 36(8):4359-66. PubMed ID: 27466557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of mammographically occult architectural distortion on digital breast tomosynthesis screening: initial clinical experience.
    Partyka L; Lourenco AP; Mainiero MB
    AJR Am J Roentgenol; 2014 Jul; 203(1):216-22. PubMed ID: 24951218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts.
    Mori M; Akashi-Tanaka S; Suzuki S; Daniels MI; Watanabe C; Hirose M; Nakamura S
    Breast Cancer; 2017 Jan; 24(1):104-110. PubMed ID: 26942415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Architectural Distortion on Digital Breast Tomosynthesis With Nonmalignant Pathology at Biopsy.
    Villa-Camacho JC; Bahl M
    AJR Am J Roentgenol; 2022 Jul; 219(1):46-54. PubMed ID: 35107312
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology-preliminary results.
    Rudnicki W; Heinze S; Niemiec J; Kojs Z; Sas-Korczynska B; Hendrick E; Luczynska E
    Eur Radiol; 2019 Nov; 29(11):6220-6226. PubMed ID: 31089850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts.
    Lu Z; Hao C; Pan Y; Mao N; Wang X; Yin X
    Korean J Radiol; 2020 Apr; 21(4):442-449. PubMed ID: 32193892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced spectral mammography (CESM) in women presenting with palpable breast findings.
    Sorin V; Faermann R; Yagil Y; Shalmon A; Gotlieb M; Halshtok-Neiman O; Ben-David MA; Sklair-Levy M
    Clin Imaging; 2020 May; 61():99-105. PubMed ID: 32014818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding the power of iodinated contrast media to the credibility of mammography in breast cancer diagnosis.
    Tsigginou A; Gkali C; Chalazonitis A; Feida E; Vlachos DE; Zagouri F; Rellias I; Dimitrakakis C
    Br J Radiol; 2016 Nov; 89(1067):20160397. PubMed ID: 27452266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of enhancement in contrast-enhanced spectral mammography using a custom-made quantifier tool (I-STRIP): A proof-of-concept study.
    Lobbes MBI; Mulder HKP; Rousch M; Backes WH; Wildberger JE; Jeukens CRLPN
    Eur J Radiol; 2018 Sep; 106():114-121. PubMed ID: 30150032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits.
    Houben IPL; Van de Voorde P; Jeukens CRLPN; Wildberger JE; Kooreman LF; Smidt ML; Lobbes MBI
    Eur J Radiol; 2017 Sep; 94():31-37. PubMed ID: 28941757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Evaluation of Contrast-Enhanced Spectral Mammography and Digital Breast Tomosynthesis for Diagnosing and Treating Breast Cancer.
    Yang D; Gong F
    Med Sci Monit; 2023 Dec; 29():e941880. PubMed ID: 38087777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
    Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
    AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.